JabWatch journal

NHS splurged at least £750 million on fat jabs last year - spend on Mounjaro tripled in 2025, new figures show

Source published 21 August 2026 · JabWatch published 26 August 2026 · Last updated 26 August 2026

NHS spending on GLP-1 weight-loss medicines reached at least £750 million last year, with expenditure on Mounjaro reportedly tripling in 2025. The total was more than twice the funding allocated to the Cancer Drugs Fund.

Original source

This JabWatch summary links to the original report: Daily Mail Health.

Context

JabWatch provides consumer price information, not medical advice. Check the original source and a pharmacy's terms for the latest details.